Genetics References Clinical studies Fra(X)(p22) not associated with infantile autism. Lancet 1984; 2

Download 0.6 Mb.
Date conversion29.03.2017
Size0.6 Mb.
1   ...   4   5   6   7   8   9   10   11   12
46(2): 142-144.

113. Gustavsson P, Kimber E, Wahlstrom J, Anneren G. Monosomy 18q syndrome and atypical Rett syndrome in a girl with an interstitial deletion (18)(q21.1q22.3). Am J Med Genet 1999; 82(4): 348-351.
114. Gutierrez-Roelens I, De Roy L, Ovaert C, Sluysmans T, Devriendt K, Brunner HG et al. A novel CSX/NKX2-5 mutation causes autosomal-dominant AV block: are atrial fibrillation and syncopes part of the phenotype? Eur J Hum Genet 2006; 14(12): 1313-1316.
115. Gutierrez-Roelens I, Sluysmans T, Gewillig M, Devriendt K, Vikkula M. Progressive AV-block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKX2-5 gene. Hum Mutat 2002; 20(1): 75-76.
116. Haas RH, Nasirian F, Hua X, Nakano K, Hennessy M. Oxidative metabolism in Rett syndrome: 2. Biochemical and molecular studies. Neuropediatrics 1995; 26(2): 95-99.
117. Hammer S, Dorrani N, Hartiala J, Stein S, Schanen NC. Rett syndrome in a 47,XXX patient with a de novo MECP2 mutation. Am J Med Genet A 2003; 122A(3): 223-226.

118. Hampson K, Woods CG, Latif F, Webb T. Mutations in the MECP2 gene in a cohort of girls with Rett syndrome. J Med Genet 2000; 37(8): 610-612.

119. Hanefeld F, Hanefeld U, Wilichowski E, Schmidtke J. Rett syndrome--search for genetic markers. Am J Med Genet Suppl 1986; 1: 377-382.
120. Hardwick SA, Reuter K, Williamson SL, Vasudevan V, Donald J, Slater K et al. Delineation of large deletions of the MECP2 gene in Rett syndrome patients, including a familial case with a male proband. Eur J Hum Genet 2007; 15(12): 1218-1229.
121. Hebebrand J, Warnke A, Remschmidt H. [Significant progress in the genetic origin of Martin-Bell syndrome including diagnostic consequences]. Z Kinder Jugendpsychiatr 1992; 20(3): 197-202.
122. Heidary G, Hampton LL, Schanen NC, Rivkin MJ, Darras BT, Battey J et al. Exclusion of the gastrin-releasing peptide receptor (GRPR) locus as a candidate gene for Rett syndrome. Am J Med Genet 1998; 78(2): 173-175.
123. Hoffbuhr KC, Moses LM, Jerdonek MA, Naidu S, Hoffman EP. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Ment Retard Dev Disabil Res Rev 2002; 8(2): 99-105.

124. Hofferbert S, Schanen NC, Budden SS, Francke U. Is Rett syndrome caused by a triplet repeat expansion? Neuropediatrics 1997; 28(3): 179-183.

125. Horike S, Cai S, Miyano M, Cheng JF, Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 2005; 37(1): 31-40.
126. Horska A, Farage L, Bibat G, Nagae LM, Kaufmann WE, Barker PB et al. Brain metabolism in Rett syndrome: age, clinical, and genotype correlations. Ann Neurol 2009; 65(1): 90-97.
127. Hung AY, Futai K, Sala C, Valtschanoff JG, Ryu J, Woodworth MA et al. Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J Neurosci 2008; 28(7): 1697-1708.
128. Hung CC, Yeh JI, Fang JS, Chen CH. No association of a dodecamer duplication in the human opposite paired (HOPA) gene with mental retardation and schizophrenia in Chinese patients from Taiwan. Psychiatry Res 2003; 119(1-2): 163-166.
129. Huppke P, Bohlander S, Kramer N, Laccone F, Hanefeld F. Altered methylation pattern of the G6 PD promoter in Rett syndrome. Neuropediatrics 2002; 33(2): 105-108.

130. Huppke P, Held M, Hanefeld F, Engel W, Laccone F. Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. Neuropediatrics 2002; 33(2): 63-68.

131. Huppke P, Kohler K, Laccone F, Hanefeld F. Indication for genetic testing: a checklist for Rett syndrome. J Pediatr 2003; 142(3): 332-335.
132. Huppke P, Laccone F, Kramer N, Engel W, Hanefeld F. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet 2000; 9(9): 1369-1375.
133. Huppke P, Maier EM, Warnke A, Brendel C, Laccone F, Gartner J. Very mild cases of Rett syndrome with skewed X inactivation. J Med Genet 2006; 43(10): 814-816.
134. Huppke P, Ohlenbusch A, Brendel C, Laccone F, Gartner J. Mutation analysis of the HDAC 1, 2, 8 and CDKL5 genes in Rett syndrome patients without mutations in MECP2. Am J Med Genet A 2005; 137(2): 136-138.
135. Inui K, Akagi M, Ono J, Tsukamoto H, Shimono K, Mano T et al. Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome. Brain Dev 2001; 23(4): 212-215.

136. Ishii T, Makita Y, Ogawa A, Amamiya S, Yamamoto M, Miyamoto A et al. The role of different X-inactivation pattern on the variable clinical phenotype with Rett syndrome. Brain Dev 2001; 23 Suppl 1: S161-164.

137. Itaba-Matsumoto N, Maegawa S, Yamagata H, Kondo I, Oshimura M, Nanba E. Imprinting status of paternally imprinted DLX5 gene in Japanese patients with Rett syndrome. Brain Dev 2007; 29(8): 491-495.
138. Itoh M, Ide S, Takashima S, Kudo S, Nomura Y, Segawa M et al. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. J Neuropathol Exp Neurol 2007; 66(2): 117-123.
139. Iurov I, Vorsanova SG, Voinova-Ulas V, Villard L, Demidova IA, Giunti L et al. [Epigenetic study of Rett's syndrome as an adequate model for autistic disorders]. Zh Nevrol Psikhiatr Im S S Korsakova 2005; 105(7): 4-11.
140. Jacob FD, Ramaswamy V, Andersen J, Bolduc FV. Atypical Rett syndrome with selective FOXG1 deletion detected by comparative genomic hybridization: case report and review of literature. Eur J Hum Genet 2009; 17(12): 1577-1581.
141. Jian L, Archer HL, Ravine D, Kerr A, de Klerk N, Christodoulou J et al. p.R270X MECP2 mutation and mortality in Rett syndrome. Eur J Hum Genet 2005; 13(11): 1235-1238.

142. Jiang SL, Bao XH, Song FY, Pan H, Li MR, Wu XR. [X chromosome inactivation patterns in patients with Rett syndrome and their mothers and the parental origin of the priority inactive X chromosome]. Zhonghua Er Ke Za Zhi 2006; 44(9): 648-652.

143. Jones W, Bellugi U, Lai Z, Chiles M, Reilly J, Lincoln A et al. II. Hypersociability in Williams Syndrome. J Cogn Neurosci 2000; 12 Suppl 1: 30-46.
144. Journel H, Melki J, Turleau C, Munnich A, de Grouchy J. Rett phenotype with X/autosome translocation: possible mapping to the short arm of chromosome X. Am J Med Genet 1990; 35(1): 142-147.
145. Kammoun F, de Roux N, Boespflug-Tanguy O, Vallee L, Seng R, Tardieu M et al. Screening of MECP2 coding sequence in patients with phenotypes of decreasing likelihood for Rett syndrome: a cohort of 171 cases. J Med Genet 2004; 41(6): e85.
146. Karall D, Haberlandt E, Scholl-Burgi S, Baumgartner S, Naudo M, Martorell L. Homozygosity for MECP2 gene in a girl with classical Rett syndrome. Eur J Med Genet 2007; 50(6): 465-468.
147. Karteszi J, Hollody K, Bene J, Morava E, Hadzsiev K, Czako M et al. [Mutational analysis of the MECP2 gene by direct sequencing in Hungarian patients with Rett syndrome]. Orv Hetil 2004; 145(17): 909-911.

148. Karteszi J, Hollody K, Bene J, Morava E, Hadzsiev K, Czako M et al. Mutation analysis of MECP2 and determination of the X-inactivation pattern in Hungarian Rett syndrome patients. Am J Med Genet A 2004; 131(1): 106.

149. Kaufmann WE, Jarrar MH, Wang JS, Lee YJ, Reddy S, Bibat G et al. Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation. Brain Dev 2005; 27(5): 331-339.
150. Khajuria R, Sapra S, Ghosh M, Gupta N, Gulati S, Kalra V et al. Rapid detection of deletions in hotspot C-terminal segment region of MECP2 by routine PCR method: report of two classical Rett syndrome patients of Indian origin. Genet Test Mol Biomarkers 2009; 13(2): 277-280.
151. Killian W. On the genetics of Rett syndrome: analysis of family and pedigree data. Am J Med Genet Suppl 1986; 1: 369-376.
152. Kim IJ, Kim YJ, Son BH, Nam SO, Kang HC, Kim HD et al. Diagnostic mutational analysis of MECP2 in Korean patients with Rett syndrome. Exp Mol Med 2006; 38(2): 119-125.
153. Kim SJ, Cook EH, Jr. Novel de novo nonsense mutation of MECP2 in a patient with Rett syndrome. Hum Mutat 2000; 15(4): 382-383.
154. Kishi N, Macklis JD. Dissecting MECP2 function in the central nervous system. J Child Neurol 2005; 20(9): 753-759.

155. Kishi N, Macklis JD. MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons. Exp Neurol 2010; 222(1): 51-58.

156. Kondo I, Yamagata H. [Mutation spectrum and genotype-phenotype correlation of MECP2 in patients with Rett syndrome]. No To Hattatsu 2002; 34(3): 219-223.
157. Kondo M, Gray LJ, Pelka GJ, Christodoulou J, Tam PP, Hannan AJ. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression. Eur J Neurosci 2008; 27(12): 3342-3350.
158. Kormann-Bortolotto MH, Webb T. Alterations in replication timing of X-chromosome bands in Rett syndrome. J Intellect Disabil Res 1995; 39 ( Pt 2): 91-96.
159. Kormann-Bortolotto MH, Woods CG, Green SH, Webb T. X-inactivation in girls with Rett syndrome. Clin Genet 1992; 42(6): 296-301.
160. Krepischi AC, Kok F, Otto PG. X chromosome-inactivation patterns in patients with Rett syndrome. Hum Genet 1998; 102(3): 319-321.
161. Kriaucionis S, Bird A. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res 2004; 32(5): 1818-1823.

162. Kudo S, Nomura Y, Segawa M, Fujita N, Nakao M, Dragich J et al. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems. Brain Dev 2001; 23 Suppl 1: S165-173.

163. Kumar A, Kamboj S, Malone BM, Kudo S, Twiss JL, Czymmek KJ et al. Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J Cell Sci 2008; 121(Pt 7): 1128-1137.
164. Laccone F, Huppke P, Hanefeld F, Meins M. Mutation spectrum in patients with Rett syndrome in the German population: Evidence of hot spot regions. Hum Mutat 2001; 17(3): 183-190.
165. Laccone F, Junemann I, Whatley S, Morgan R, Butler R, Huppke P et al. Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome. Hum Mutat 2004; 23(3): 234-244.
166. Lane R, He Y, Morris C, Leverenz JB, Emre M, Ballard C. BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Mov Disord 2009; 24(3): 392-400.
167. Langford PR, Loynds BM, Kroll JS. Cloning and molecular characterization of Cu,Zn superoxide dismutase from Actinobacillus pleuropneumoniae. Infect Immun 1996; 64(12): 5035-5041.

168. Largo RH, Schinzel A. Developmental and behavioural disturbances in 13 boys with fragile X syndrome. Eur J Pediatr 1985; 143(4): 269-275.

169. Larimore JL, Chapleau CA, Kudo S, Theibert A, Percy AK, Pozzo-Miller L. Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol Dis 2009; 34(2): 199-211.
170. LaSalle JM, Goldstine J, Balmer D, Greco CM. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum Mol Genet 2001; 10(17): 1729-1740.
171. Lebo RV, Ikuta T, Milunsky JM, Milunsky A. Rett syndrome from quintuple and triple deletions within the MECP2 deletion hotspot region. Clin Genet 2001; 59(6): 406-417.
172. Ledbetter DH. Cytogenetic technology--genotype and phenotype. N Engl J Med 2008; 359(16): 1728-1730.
173. Ledenev BA, Shevchenko Iu S. [Clinical picture and dynamics of mosaic variants of schizoid (autistic) psychopathy in childhood and adolescence]. Zh Nevropatol Psikhiatr Im S S Korsakova 1983; 83(10): 1526-1533.
174. Lee SS, Wan M, Francke U. Spectrum of MECP2 mutations in Rett syndrome. Brain Dev 2001; 23 Suppl 1: S138-143.

175. Leonard H, Colvin L, Christodoulou J, Schiavello T, Williamson S, Davis M et al. Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations? J Med Genet 2003; 40(5): e52.

176. Leonard H, Fyfe S, Dye D, Hockey A, Christodoulou J. Family data in Rett syndrome: association with other genetic disorders. J Paediatr Child Health 2000; 36(4): 336-339.
177. Leonard H, Moore H, Carey M, Fyfe S, Hall S, Robertson L et al. Genotype and early development in Rett syndrome: the value of international data. Brain Dev 2005; 27 Suppl 1: S59-S68.
178. Leonard H, Silberstein J, Falk R, Houwink-Manville I, Ellaway C, Raffaele LS et al. Occurrence of Rett syndrome in boys. J Child Neurol 2001; 16(5): 333-338.
179. Leonard H, Weaving L, Eastaugh P, Smith L, Delatycki M, Witt Engerstrom I et al. Trisomy 21 and Rett syndrome: a double burden. J Paediatr Child Health 2004; 40(7): 406-409.
180. Levenson D. The AJMG SEQUENCE: Decoding news and trends for the medical genetics community. Too much? Not enough? Am J Med Genet A 2010; 152A(7): fmvii-fmviii.
181. Levin ED, Aschner M, Heberlein U, Ruden D, Welsh-Bohmer KA, Bartlett S et al. Genetic aspects of behavioral neurotoxicology. Neurotoxicology 2009; 30(5): 741-753.

182. Levin JH, Kaler SG. Non-random maternal X-chromosome inactivation associated with PHACES. Clin Genet 2007; 72(4): 345-350.

183. Levin R, Heresco-Levy U, Bachner-Melman R, Israel S, Shalev I, Ebstein RP. Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition. Psychoneuroendocrinology 2009; 34(6): 901-908.
184. Lewis JC, Thomas HV, Murphy KC, Sampson JR. Genotype and psychological phenotype in tuberous sclerosis. J Med Genet 2004; 41(3): 203-207.
185. Lewis KE, Lubetsky MJ, Wenger SL, Steele MW. Chromosomal abnormalities in a psychiatric population. Am J Med Genet 1995; 60(1): 53-54.
186. Lewis M, Kim SJ. The pathophysiology of restricted repetitive behavior. J Neurodev Disord 2009; 1(2): 114-132.
187. Lewis ME. HotSpots. Clin Genet 2002; 61(1): 7-12.
188. Lewis MH. Environmental complexity and central nervous system development and function. Ment Retard Dev Disabil Res Rev 2004; 10(2): 91-95.
189. Li MR, Pan H, Bao XH, Cao GN, Wu XR. [Application of long range polymerase chain reaction and DNA direct sequencing in diagnosis of Rett syndrome]. Zhonghua Er Ke Za Zhi 2007; 45(8): 579-582.

190. Li MR, Pan H, Bao XH, Zhang YZ, Jiang SL, Wu XR. [MECP2 gene mutations in twenty-six cases with atypical Rett syndrome]. Zhonghua Er Ke Za Zhi 2006; 44(4): 285-288.

191. Li MR, Pan H, Bao XH, Zhang YZ, Wu XR. MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome. J Hum Genet 2007; 52(1): 38-47.
192. Li MR, Pan H, Bao XH, Zhu XW, Cao GN, Zhang YZ et al. [Correlation between MECP2 genotype and phenotype in Chinese patients with Rett syndrome]. Zhonghua Er Ke Za Zhi 2009; 47(2): 124-128.
193. Li MR, Pan H, Bao XH, Zhu XW, Cao GN, Zhang YZ et al. [Methyl-CpG-binding protein 2 gene and CDKL5 gene mutation in patients with Rett syndrome: analysis of 177 Chinese pediatric patients]. Zhonghua Yi Xue Za Zhi 2009; 89(4): 224-229.
194. Lima FT, Brunoni D, Schwartzman JS, Pozzi MC, Kok F, Juliano Y et al. Genotype-phenotype correlation in Brazillian Rett syndrome patients. Arq Neuropsiquiatr 2009; 67(3A): 577-584.
195. Longo I, Russo L, Meloni I, Ricci I, Ariani F, Pescucci C et al. Three Rett patients with both MECP2 mutation and 15q11-13 rearrangements. Eur J Hum Genet 2004; 12(8): 682-685.
196. Lundvall M, Samuelsson L, Kyllerman M. Male Rett phenotypes in T158M and R294X MeCP2-mutations. Neuropediatrics 2006; 37(5): 296-301.

197. Maiwald R, Bonte A, Jung H, Bitter P, Storm Z, Laccone F et al. De novo MECP2 mutation in a 46,XX male patient with Rett syndrome. Neurogenetics 2002; 4(2): 107-108.

198. Makrythanasis P, Kapranov P, Bartoloni L, Reymond A, Deutsch S, Guigo R et al. Variation in novel exons (RACEfrags) of the MECP2 gene in Rett syndrome patients and controls. Hum Mutat 2009; 30(9): E866-879.
199. Makrythanasis P, Moix I, Gimelli S, Fluss J, Aliferis K, Antonarakis SE et al. De novo duplication of MECP2 in a girl with mental retardation and no obvious dysmorphic features. Clin Genet 2010; 78(2): 175-180.
200. Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 2005; 14(14): 1935-1946.
201. Mari F, Caselli R, Russo S, Cogliati F, Ariani F, Longo I et al. Germline mosaicism in Rett syndrome identified by prenatal diagnosis. Clin Genet 2005; 67(3): 258-260.
202. Martinho PS, Otto PG, Kok F, Diament A, Marques-Dias MJ, Gonzalez CH. In search of a genetic basis for the Rett syndrome. Hum Genet 1990; 86(2): 131-134.

203. Masuyama T, Matsuo M, Jing JJ, Tabara Y, Kitsuki K, Yamagata H et al. Classic Rett syndrome in a boy with R133C mutation of MECP2. Brain Dev 2005; 27(6): 439-442.

204. Matijevic T, Knezevic J, Barisic I, Resic B, Culic V, Pavelic J. The MECP2 gene mutation screening in Rett syndrome patients from Croatia. Ann N Y Acad Sci 2006; 1091: 225-232.
205. Meins M, Lehmann J, Gerresheim F, Herchenbach J, Hagedorn M, Hameister K et al. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J Med Genet 2005; 42(2): e12.
206. Meloni I, Bruttini M, Longo I, Mari F, Rizzolio F, D'Adamo P et al. A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet 2000; 67(4): 982-985.
207. Mencarelli MA, Kleefstra T, Katzaki E, Papa FT, Cohen M, Pfundt R et al. 14q12 Microdeletion syndrome and congenital variant of Rett syndrome. Eur J Med Genet 2009; 52(2-3): 148-152.
208. Mencarelli MA, Spanhol-Rosseto A, Artuso R, Rondinella D, De Filippis R, Bahi-Buisson N et al. Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. J Med Genet 2010; 47(1): 49-53.

209. Migeon BR, Dunn MA, Thomas G, Schmeckpeper BJ, Naidu S. Studies of X inactivation and isodisomy in twins provide further evidence that the X chromosome is not involved in Rett syndrome. Am J Hum Genet 1995; 56(3): 647-653.

210. Milani D, Pantaleoni C, D'Arrigo S, Selicorni A, Riva D. Another patient with MECP2 mutation without classic Rett syndrome phenotype. Pediatr Neurol 2005; 32(5): 355-357.
211. Milunsky JM, Lebo RV, Ikuta T, Maher TA, Haverty CE, Milunsky A. Mutation analysis in Rett syndrome. Genet Test 2001; 5(4): 321-325.
212. Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJ et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 2004; 36(4): 339-341.
213. Monnerat LS, Moreira Ados S, Alves MC, Bonvicino CR, Vargas FR. Identification and characterization of novel sequence variations in MECP2 gene in Rett syndrome patients. Brain Dev 2010; 32(10): 843-848.
214. Monros E, Armstrong J, Aibar E, Poo P, Canos I, Pineda M. Rett syndrome in Spain: mutation analysis and clinical correlations. Brain Dev 2001; 23 Suppl 1: S251-253.

215. Moog U, Smeets EE, van Roozendaal KE, Schoenmakers S, Herbergs J, Schoonbrood-Lenssen AM et al. Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J Paediatr Neurol 2003; 7(1): 5-12.

216. Moog U, Van Roozendaal K, Smeets E, Tserpelis D, Devriendt K, Buggenhout GV et al. MECP2 mutations are an infrequent cause of mental retardation associated with neurological problems in male patients. Brain Dev 2006; 28(5): 305-310.
217. Moore JW, Tuck-Muller CM, Murphy M, Naidu S, Thomas GH. Chromosome studies in 10 patients with the Rett syndrome. Am J Med Genet Suppl 1986; 1: 345-354.
218. Narayanan V, Olinsky S, Dahle E, Naidu S, Zoghbi HY. Mutation analysis of the M6b gene in patients with Rett syndrome. Am J Med Genet 1998; 78(2): 165-168.
219. Nectoux J, Bahi-Buisson N, Guellec I, Coste J, De Roux N, Rosas H et al. The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome. Neurology 2008; 70(22 Pt 2): 2145-2151.
220. Nectoux J, Fichou Y, Rosas-Vargas H, Cagnard N, Bahi-Buisson N, Nusbaum P et al. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes. J Cell Mol Med 2010; 14(7): 1962-1974.

221. Nectoux J, Girard B, Bahi-Buisson N, Prieur F, Afenjar A, Rosas-Vargas H et al. Netrin G1 mutations are an uncommon cause of atypical Rett syndrome with or without epilepsy. Pediatr Neurol 2007; 37(4): 270-274.

222. Nectoux J, Heron D, Tallot M, Chelly J, Bienvenu T. Maternal origin of a novel C-terminal truncation mutation in CDKL5 causing a severe atypical form of Rett syndrome. Clin Genet 2006; 70(1): 29-33.
223. Neul JL, Fang P, Barrish J, Lane J, Caeg EB, Smith EO et al. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology 2008; 70(16): 1313-1321.
224. Nicolao P, Carella M, Giometto B, Tavolato B, Cattin R, Giovannucci-Uzielli ML et al. DHPLC analysis of the MECP2 gene in Italian Rett patients. Hum Mutat 2001; 18(2): 132-140.
225. Nielsen JB, Henriksen KF, Hansen C, Silahtaroglu A, Schwartz M, Tommerup N. MECP2 mutations in Danish patients with Rett syndrome: high frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern. Eur J Hum Genet 2001; 9(3): 178-184.
226. Nielsen JB, Ravn K, Schwartz M. A 77-year-old woman and a preserved speech variant among the Danish Rett patients with mutations in MECP2. Brain Dev 2001; 23 Suppl 1: S230-232.

227. Nikitina T, Ghosh RP, Horowitz-Scherer RA, Hansen JC, Grigoryev SA, Woodcock CL. MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. J Biol Chem 2007; 282(38): 28237-28245.

228. Obata K, Matsuishi T, Yamashita Y, Fukuda T, Kuwajima K, Horiuchi I et al. Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome. J Med Genet 2000; 37(8): 608-610.
229. Pan H, Li MR, Nelson P, Bao XH, Wu XR, Yu S. Large deletions of the MECP2 gene in Chinese patients with classical Rett syndrome. Clin Genet 2006; 70(5): 418-419.
230. Pan H, Wang Y, Meng H, Bao X, Zhang Y, Shen Y et al. [Mutational analysis of MECP2 gene in Rett syndrome]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002; 19(4): 276-280.
231. Pan H, Wang YP, Bao XH, Meng HD, Zhang Y, Wu XR et al. MECP2 gene mutation analysis in Chinese patients with Rett syndrome. Eur J Hum Genet 2002; 10(8): 484-486.
232. Panasiuk B, Midro AT, Zadrozna-Tolwinska B. Earlier finishing of Xp21.2 subband replication of the inactive X chromosome in Rett syndrome girl but not in her 47,XXX mother. Clin Genet 1997; 52(2): 120-125.

233. Papa FT, Mencarelli MA, Caselli R, Katzaki E, Sampieri K, Meloni I et al. A 3 Mb deletion in 14q12 causes severe mental retardation, mild facial dysmorphisms and Rett-like features. Am J Med Genet A 2008; 146A(15): 1994-1998.

234. Parmeggiani A, Tedde MR, Arbizzani A, Posar A, Scaduto MC, Santucci M et al. Methyl-CpG-binding protein 2 (MECP2) gene mutations in an Italian sample of patients with pervasive developmental disorder and mental retardation. J Child Neurol 2009; 24(6): 772-774.
235. Petel-Galil Y, Benteer B, Galil YP, Zeev BB, Greenbaum I, Vecsler M et al. Comprehensive diagnosis of Rett's syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: study of a cohort of Israeli patients. J Med Genet 2006; 43(12): e56.
236. Philippe C, Amsallem D, Francannet C, Lambert L, Saunier A, Verneau F et al. Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females. J Med Genet 2010; 47(1): 59-65.
237. Philippe C, Villard L, De Roux N, Raynaud M, Bonnefond JP, Pasquier L et al. Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update. Eur J Med Genet 2006; 49(1): 9-18.

238. Popescu AC, Sidorova E, Zhang G, Eubanks JH. Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro. J Neurosci Res 2010; 88(11): 2316-2324.

239. Pruissen DM, Sinke RJ, Terhal PA, Beemer FA, Peters AC. [Developmental disorder in girls due to Rett syndrome]. Ned Tijdschr Geneeskd 2003; 147(32): 1560-1563.
240. Qi Y, Wu X, Tang J, Bao X. [Computerized ribosomal RNA secondary structure modeling of mutants found in Rett syndrome patients and their mothers]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 1999; 16(3): 153-155.
241. Quenard A, Yilmaz S, Fontaine H, Bienvenu T, Moncla A, des Portes V et al. Deleterious mutations in exon 1 of MECP2 in Rett syndrome. Eur J Med Genet 2006; 49(4): 313-322.
242. Raizis AM, Saleem M, MacKay R, George PM. Spectrum of MECP2 mutations in New Zealand Rett syndrome patients. N Z Med J 2009; 122(1296): 21-28.
243. Ravn K, Nielsen JB, Schwartz M. Mutations found within exon 1 of MECP2 in Danish patients with Rett syndrome. Clin Genet 2005; 67(6): 532-533.
244. Rivkin MJ, Ye Z, Mannheim GB, Darras BT. A search for X-chromosome uniparental disomy and DNA rearrangements in the Rett syndrome. Brain Dev 1992; 14(4): 273-275.

245. Robertson L, Hall SE, Jacoby P, Ellaway C, de Klerk N, Leonard H. The association between behavior and genotype in Rett syndrome using the Australian Rett Syndrome Database. Am J Med Genet B Neuropsychiatr Genet 2006; 141B(2): 177-183.

246. Romeo G, Archidiacono N, Ferlini A, Rocchi M. Rett syndrome: lack of association with fragile site Xp22 and strategy for genetic mapping of X-linked new mutations. Am J Med Genet Suppl 1986; 1: 355-359.
247. Rosenberg C, Wouters CH, Szuhai K, Dorland R, Pearson P, Poll-The BT et al. A Rett syndrome patient with a ring X chromosome: further evidence for skewing of X inactivation and heterogeneity in the aetiology of the disease. Eur J Hum Genet 2001; 9(3): 171-177.
248. Rosipal R, Zeman J, Hadac J, Misovicova N, Nevsimalova S, Martasek P. [Analysis of the most frequent mutations in girls with Rett syndrome]. Cas Lek Cesk 2001; 140(15): 473-476.
249. Rosser LG, McKee S, Millar DS, Archer H, Hughes J, Butler R et al. Two sisters with Rett syndrome and non-identical paternally-derived microdeletions in the MECP2 gene. Genomic Med 2008; 2(3-4): 77-81.
250. Salomao Schwartzman J, Zatz M, dos Reis Vasquez L, Ribeiro Gomes R, Koiffmann CP, Fridman C et al. Rett syndrome in a boy with a 47,XXY karyotype. Am J Hum Genet 1999; 64(6): 1781-1785.

251. Santos M, Temudo T, Kay T, Carrilho I, Medeira A, Cabral H et al. Mutations in the MECP2 gene are not a major cause of Rett syndrome-like or related neurodevelopmental phenotype in male patients. J Child Neurol 2009; 24(1): 49-55.

252. Santos M, Yan J, Temudo T, Oliveira G, Vieira JP, Fen J et al. Analysis of highly conserved regions of the 3'UTR of MECP2 gene in patients with clinical diagnosis of Rett syndrome and other disorders associated with mental retardation. Dis Markers 2008; 24(6): 319-324.
253. Sartori S, Di Rosa G, Polli R, Bettella E, Tricomi G, Tortorella G et al. A novel CDKL5 mutation in a 47,XXY boy with the early-onset seizure variant of Rett syndrome. Am J Med Genet A 2009; 149A(2): 232-236.
254. Saunders CJ, Friez MJ, Patterson M, Nzabi M, Zhao W, Bi C. Allele drop-out in the MECP2 gene due to G-quadruplex and i-motif sequences when using polymerase chain reaction-based diagnosis for Rett syndrome. Genet Test Mol Biomarkers 2010; 14(2): 241-247.
255. Saunders CJ, Minassian BE, Chow EW, Zhao W, Vincent JB. Novel exon 1 mutations in MECP2 implicate isoform MeCP2_e1 in classical Rett syndrome. Am J Med Genet A 2009; 149A(5): 1019-1023.
256. Scala E, Ariani F, Mari F, Caselli R, Pescucci C, Longo I et al. CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J Med Genet 2005; 42(2): 103-107.

257. Scala E, Longo I, Ottimo F, Speciale C, Sampieri K, Katzaki E et al. MECP2 deletions and genotype-phenotype correlation in Rett syndrome. Am J Med Genet A 2007; 143A(23): 2775-2784.

258. Schanen C, Francke U. A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map. Am J Hum Genet 1998; 63(1): 267-269.
259. Schanen C, Houwink EJ, Dorrani N, Lane J, Everett R, Feng A et al. Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. Am J Med Genet A 2004; 126A(2): 129-140.
260. Schanen NC, Dahle EJ, Capozzoli F, Holm VA, Zoghbi HY, Francke U. A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am J Hum Genet 1997; 61(3): 634-641.
261. Schirmbeck F, Georgi A, Strohmaier J, Schmael C, Boesshenz KV, Muhleisen TW et al. Brief report: no association between premorbid adjustment in adult-onset schizophrenia and genetic variation in Dysbindin. J Autism Dev Disord 2008; 38(10): 1977-1981.
262. Schollen E, Smeets E, Deflem E, Fryns JP, Matthijs G. Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: implications for routine diagnosis of Rett syndrome. Hum Mutat 2003; 22(2): 116-120.

263. Schork NJ, Greenwood TA. Inherent bias toward the null hypothesis in conventional multipoint nonparametric linkage analysis. Am J Hum Genet 2004; 74(2): 306-316.

264. Schwartzman JS, Bernardino A, Nishimura A, Gomes RR, Zatz M. Rett syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene. Neuropediatrics 2001; 32(3): 162-164.
265. Shahbazian MD, Sun Y, Zoghbi HY. Balanced X chromosome inactivation patterns in the Rett syndrome brain. Am J Med Genet 2002; 111(2): 164-168.
266. Shapiro JR, Bibat G, Hiremath G, Blue ME, Hundalani S, Yablonski T et al. Bone mass in Rett syndrome: association with clinical parameters and MECP2 mutations. Pediatr Res 2010; 68(5): 446-451.
267. Shi J, Shibayama A, Liu Q, Nguyen VQ, Feng J, Santos M et al. Detection of heterozygous deletions and duplications in the MECP2 gene in Rett syndrome by Robust Dosage PCR (RD-PCR). Hum Mutat 2005; 25(5): 505.
268. Sirianni N, Naidu S, Pereira J, Pillotto RF, Hoffman EP. Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet 1998; 63(5): 1552-1558.

269. Smeets E, Schollen E, Moog U, Matthijs G, Herbergs J, Smeets H et al. Rett syndrome in adolescent and adult females: clinical and molecular genetic findings. Am J Med Genet A 2003; 122A(3): 227-233.

270. Smeets E, Terhal P, Casaer P, Peters A, Midro A, Schollen E et al. Rett syndrome in females with CTS hot spot deletions: a disorder profile. Am J Med Genet A 2005; 132A(2): 117-120.
271. Smith RG, Kember RL, Mill J, Fernandes C, Schalkwyk LC, Buxbaum JD et al. Advancing paternal age is associated with deficits in social and exploratory behaviors in the offspring: a mouse model. PLoS One 2009; 4(12): e8456.
272. Sprovieri T, Conforti FL, Fiumara A, Mazzei R, Ungaro C, Citrigno L et al. A novel mutation in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene associated with a severe Rett phenotype. Am J Med Genet A 2009; 149A(4): 722-725.
273. Stachon A, Assumpcao FB, Jr., Raskin S. Rett syndrome: clinical and molecular characterization of two Brazilian patients. Arq Neuropsiquiatr 2007; 65(1): 36-40.
274. Stamm LV, Walker RL, Read DH. Genetic diversity of bovine ulcerative mammary dermatitis-associated Treponema. Vet Microbiol 2009; 136(1-2): 192-196.

275. Stancheva I, Collins AL, Van den Veyver IB, Zoghbi H, Meehan RR. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol Cell 2003; 12(2): 425-435.

276. Sun G, Yan J, Noltner K, Feng J, Li H, Sarkis DA et al. SNPs in human miRNA genes affect biogenesis and function. RNA 2009; 15(9): 1640-1651.
277. Takahashi S, Ohinata J, Makita Y, Suzuki N, Araki A, Sasaki A et al. Skewed X chromosome inactivation failed to explain the normal phenotype of a carrier female with MECP2 mutation resulting in Rett syndrome. Clin Genet 2008; 73(3): 257-261.
278. Tang J, Qi Y, Bao X. [Mutation analysis of mitochondrial DNA of children with Rett syndrome]. Zhonghua Yi Xue Za Zhi 1996; 76(9): 684-687.
279. Tang J, Qi Y, Bao XH, Wu XR. Mutational analysis of mitochondrial DNA of children with Rett syndrome. Pediatr Neurol 1997; 17(4): 327-330.
280. Tariverdian G. Follow-up of monozygotic twins concordant for the Rett syndrome. Brain Dev 1990; 12(1): 125-127.
281. Tariverdian G, Kantner G, Vogel F. A monozygotic twin pair with Rett syndrome. Hum Genet 1987; 75(1): 88-90.
282. Telvi L, Leboyer M, Chiron C, Feingold J, Ponsot G. Is Rett syndrome a chromosome breakage syndrome? Am J Med Genet 1994; 51(4): 602-605.

283. Temple CM. Developmental and acquired dyslexias. Cortex 2006; 42(6): 898-910.

284. Temudo T, Oliveira P, Santos M, Dias K, Vieira J, Moreira A et al. Stereotypies in Rett syndrome: analysis of 83 patients with and without detected MECP2 mutations. Neurology 2007; 68(15): 1183-1187.
285. Temudo T, Ramos E, Dias K, Barbot C, Vieira JP, Moreira A et al. Movement disorders in Rett syndrome: an analysis of 60 patients with detected MECP2 mutation and correlation with mutation type. Mov Disord 2008; 23(10): 1384-1390.
286. Thony B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 2000; 347 Pt 1: 1-16.
287. Topcu M, Akyerli C, Sayi A, Toruner GA, Kocoglu SR, Cimbis M et al. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet 2002; 10(1): 77-81.
288. Trappe R, Laccone F, Cobilanschi J, Meins M, Huppke P, Hanefeld F et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet 2001; 68(5): 1093-1101.

289. Traynor J, Agarwal P, Lazzeroni L, Francke U. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med Genet 2002; 3: 12.

290. Vacca M, Filippini F, Budillon A, Rossi V, Della Ragione F, De Bonis ML et al. MECP2 gene mutation analysis in the British and Italian Rett Syndrome patients: hot spot map of the most recurrent mutations and bioinformatic analysis of a new MECP2 conserved region. Brain Dev 2001; 23 Suppl 1: S246-250.
291. Vacca M, Filippini F, Budillon A, Rossi V, Mercadante G, Manzati E et al. Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females. J Mol Med (Berl) 2001; 78(11): 648-655.
292. Van den Veyver IB, Subramanian S, Zoghbi HY. Genomic structure of a human holocytochrome c-type synthetase gene in Xp22.3 and mutation analysis in patients with Rett syndrome. Am J Med Genet 1998; 78(2): 179-181.
293. Venancio M, Santos M, Pereira SA, Maciel P, Saraiva JM. An explanation for another familial case of Rett syndrome: maternal germline mosaicism. Eur J Hum Genet 2007; 15(8): 902-904.
294. Venkitaramani DV, Lombroso PJ. Molecular basis of genetic neuropsychiatric disorders. Child Adolesc Psychiatr Clin N Am 2007; 16(3): 541-556.

295. Venter PA, Op't Hof J, Coetzee DJ. The Martin-Bell syndrome in South Africa. Am J Med Genet 1986; 23(1-2): 597-610.

296. Villard L, Kpebe A, Cardoso C, Chelly PJ, Tardieu PM, Fontes M. Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology 2000; 55(8): 1188-1193.
297. Villard L, Levy N, Xiang F, Kpebe A, Labelle V, Chevillard C et al. Segregation of a totally skewed pattern of X chromosome inactivation in four familial cases of Rett syndrome without MECP2 mutation: implications for the disease. J Med Genet 2001; 38(7): 435-442.
298. Vorsanova SG, Demidova IA, Ulas V, Soloviev IV, Kazantzeva LZ, Yurov Yu B. Cytogenetic and molecular-cytogenetic investigation of Rett syndrome: analysis of 31 cases. Neuroreport 1996; 8(1): 187-189.
299. Vorsanova SG, Ulas V, Iurov Iu B, Giovanucci-Uzielli ML, Demidova IA, Gianti L et al. [Genotype-phenotype correlations in Rett syndrome: the study of Russian cohort of patients]. Zh Nevrol Psikhiatr Im S S Korsakova 2002; 102(10): 23-29.
300. Vorsanova SG, Yurov YB, Kolotii AD, Soloviev IV. FISH analysis of replication and transcription of chromosome X loci: new approach for genetic analysis of Rett syndrome. Brain Dev 2001; 23 Suppl 1: S191-195.

301. Vorsanova SG, Yurov YB, Ulas VY, Demidova IA, Sharonin VO, Kolotii AD et al. Cytogenetic and molecular-cytogenetic studies of Rett syndrome (RTT): a retrospective analysis of a Russian cohort of RTT patients (the investigation of 57 girls and three boys). Brain Dev 2001; 23 Suppl 1: S196-201.

302. Voutoufianakis S, Psoni S, Vorgia P, Tsekoura F, Kekou K, Traeger-Synodinos J et al. Coinheritance of mutated SMN1 and MECP2 genes in a child with phenotypic features of spinal muscular atrophy (SMA) type II and Rett syndrome. Eur J Paediatr Neurol 2007; 11(4): 235-239.
303. Wahlstrom J. Genetic implications of Rett syndrome. Brain Dev 1985; 7(6): 573-574.
304. Wahlstrom J, Anvret M. Chromosome findings in the Rett syndrome and a test of a two-step mutation theory. Am J Med Genet Suppl 1986; 1: 361-368.
305. Wahlstrom J, Uller A, Johannesson T, Holmqvist D, Darnfors C, Vujic M et al. Congenital variant Rett syndrome in a girl with terminal deletion of chromosome 3p. J Med Genet 1999; 36(4): 343-345.
306. Wahlstrom J, Witt-Engerstrom I, Mellquist L, Anvret M, Oden A. The Rett syndrome related to fragile X(P22) in caffeine-induced lymphocyte culture. Brain Dev 1990; 12(1): 128-130.
307. Walker T, von Komorowski G, Scheurlen W, Dorn-Beineke A, Back W, Bayerl C. Neonatal mastocytosis with pachydermic bullous skin without c-Kit 816 mutation. Dermatology 2006; 212(1): 70-72.

308. Wan M, Francke U. Evaluation of two X chromosomal candidate genes for Rett syndrome: glutamate dehydrogenase-2 (GLUD2) and rab GDP-dissociation inhibitor (GDI1). Am J Med Genet 1998; 78(2): 169-172.

309. Wan M, Lee SS, Zhang X, Houwink-Manville I, Song HR, Amir RE et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 1999; 65(6): 1520-1529.
310. Wan M, Zhao K, Lee SS, Francke U. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Hum Mol Genet 2001; 10(10): 1085-1092.
311. Wang NC, Lee CY. Molecular cloning of the aspartate 4-decarboxylase gene from Pseudomonas sp. ATCC 19121 and characterization of the bifunctional recombinant enzyme. Appl Microbiol Biotechnol 2006; 73(2): 339-348.
312. Wang NC, Lee CY. Enhanced transaminase activity of a bifunctional L-aspartate 4-decarboxylase. Biochem Biophys Res Commun 2007; 356(2): 368-373.
313. Weaving LS, Williamson SL, Bennetts B, Davis M, Ellaway CJ, Leonard H et al. Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. Am J Med Genet A 2003; 118A(2): 103-114.

314. Webb T, Clarke A, Hanefeld F, Pereira JL, Rosenbloom L, Woods CG. Linkage analysis in Rett syndrome families suggests that there may be a critical region at Xq28. J Med Genet 1998; 35(12): 997-1003.

315. Webb T, Watkiss E. A comparative study of X-inactivation in Rett syndrome probands and control subjects. Clin Genet 1996; 49(4): 189-195.
316. Webb T, Watkiss E, Woods CG. Neither uniparental disomy nor skewed X-inactivation explains Rett syndrome. Clin Genet 1993; 44(5): 236-240.
317. White R, Ho G, Schmidt S, Scheffer IE, Fischer A, Yendle SC et al. Cyclin-dependent kinase-like 5 (CDKL5) mutation screening in Rett syndrome and related disorders. Twin Res Hum Genet 2010; 13(2): 168-178.
318. Wong VC, Li SY. Rett syndrome: prevalence among Chinese and a comparison of MECP2 mutations of classic Rett syndrome with other neurodevelopmental disorders. J Child Neurol 2007; 22(12): 1397-1400.
319. Xiang F, Buervenich S, Nicolao P, Bailey ME, Zhang Z, Anvret M. Mutation screening in Rett syndrome patients. J Med Genet 2000; 37(4): 250-255.
320. Xiang F, Stenbom Y, Anvret M. MECP2 mutations in Swedish Rett syndrome clusters. Clin Genet 2002; 61(5): 384-385.

321. Xiang F, Stenbom Y, Anvret M, Hagberg B. Closely related Swedish Rett Syndrome females - none with MECP2 mutation revealed. Neuropediatrics 2001; 32(4): 217-218.

322. Xiang F, Zhang Z, Clarke A, Joseluiz P, Sakkubai N, Sarojini B et al. Chromosome mapping of Rett syndrome: a likely candidate region on the telomere of Xq. J Med Genet 1998; 35(4): 297-300.
323. Xinhua B, Shengling J, Fuying S, Hong P, Meirong L, Wu XR. X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype. J Child Neurol 2008; 23(1): 22-25.
324. Yamada Y, Miura K, Kumagai T, Hayakawa C, Miyazaki S, Matsumoto A et al. Molecular analysis of Japanese patients with Rett syndrome: Identification of five novel mutations and genotype-phenotype correlation. Hum Mutat 2001; 18(3): 253.
325. Yamashita Y, Kondo I, Fukuda T, Morishima R, Kusaga A, Iwanaga R et al. Mutation analysis of the methyl-CpG-binding protein 2 gene (MECP2) in Rett patients with preserved speech. Brain Dev 2001; 23 Suppl 1: S157-160.
326. Yaron Y, Ben Zeev B, Shomrat R, Bercovich D, Naiman T, Orr-Urtreger A. MECP2 mutations in Israel: implications for molecular analysis, genetic counseling, and prenatal diagnosis in Rett syndrome. Hum Mutat 2002; 20(4): 323-324.

327. Young HK, Barton BA, Waisbren S, Portales Dale L, Ryan MM, Webster RI et al. Cognitive and psychological profile of males with Becker muscular dystrophy. J Child Neurol 2008; 23(2): 155-162.

328. Young LJ. Oxytocin and vasopressin as candidate genes for psychiatric disorders: lessons from animal models. Am J Med Genet 2001; 105(1): 53-54.
329. Yurov YB, Vorsanova SG, Kolotii AD, Iourov IY. Molecular-cytogenetic investigation of skewed chromosome X inactivation in Rett syndrome. Brain Dev 2001; 23 Suppl 1: S214-217.
330. Zahorakova D, Jachymova M, Kemlink D, Baxova A, Martasek P. APOE epsilon4: a potential modulation factor in Rett syndrome. J Child Neurol 2010; 25(5): 546-550.
331. Zahorakova D, Rosipal R, Hadac J, Zumrova A, Bzduch V, Misovicova N et al. Mutation analysis of the MECP2 gene in patients of Slavic origin with Rett syndrome: novel mutations and polymorphisms. J Hum Genet 2007; 52(4): 342-348.
332. Zarchi O, Attias J, Gothelf D. Auditory and visual processing in Williams syndrome. Isr J Psychiatry Relat Sci 2010; 47(2): 125-131.
333. Zeev BB, Bebbington A, Ho G, Leonard H, de Klerk N, Gak E et al. The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome. Neurology 2009; 72(14): 1242-1247.

334. Zeev BB, Yaron Y, Schanen NC, Wolf H, Brandt N, Ginot N et al. Rett syndrome: clinical manifestations in males with MECP2 mutations. J Child Neurol 2002; 17(1): 20-24.

335. Zhang JJ, Bao XH, Cao GN, Jiang SL, Zhu XW, Lu HM et al. [Analysis of the parental origin of MECP2 mutations in patients with Rett syndrome]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2010; 27(2): 121-124.
336. Zhu X, Li M, Pan H, Bao X, Zhang J, Wu X. Analysis of the parental origin of de novo MECP2 mutations and X chromosome inactivation in 24 sporadic patients with Rett syndrome in China. J Child Neurol 2010; 25(7): 842-848.
337. Zoghbi HY, Ledbetter DH, Schultz R, Percy AK, Glaze DG. A de novo X;3 translocation in Rett syndrome. Am J Med Genet 1990; 35(1): 148-151.

338. Zoghbi HY, Percy AK, Schultz RJ, Fill C. Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev 1990; 12(1): 131-135.

1   ...   4   5   6   7   8   9   10   11   12

The database is protected by copyright © 2017
send message

    Main page